Dr. Osokina has been working at the Medical Centre of St. Petersburg Institute of Bioregulation and Gerontology since 2008.
Maintenance and restoration of functions of the eye, being one of the main sense organs, is among vital issues of modern medicine. 80% of information about environment people get by visual perception. Most of the professional and everyday activities have to do with visual functions, their slackening or loss has the utmost negative effect on the quality of life.
In the structure of the eye retina (nervous tunic of the eyeball) is one of the thinnest layers, being the most complex and highly differentiated tissue. Its complex structure makes it sensitive to light, allowing to perceive color and images and to convert them into a signal being sent straight to the brain. Position of the retina behind other optic structures, direct ingress of sun rays, peculiarities of the blood supply make it vulnerable to both external (sun rays, light striking, radiation) and internal factors. Retina is as a rule damaged in case of the following diseases: hypertension, diabetes mellitus, renal insufficiency etc. It should be noted that any damage of the retina can lead to the impaired vision or even to complete blindness.
Among the most frequent retinal diseases there are age-related macular degeneration, hereditary retinal degenerations (including retinitis pigmentosa), complicated myopia, diabetic retinopathy. Modern methods of treatment based on the application of the known pharmaceutical substances do not lead to significant results. Usually a prognosis for a disease in these patients is unfavorable (gradual and progressive decrease in the visual functions up to blindness).
For the first time in the world medical and ophthalmological practice an unprecedented technology for restoration and treatment of retinal functions in case of different pathologies (including macular degeneration, retinitis pigmentosa, diabetic retinopathy, thermal injuries, etc.) has been discovered.
The technology is based on peptide bioregulators, isolated from animal organs and tissues, such as retina, vessels, brain, thymus, epiphysis or their synthesized analogues. In case of introduction into the organism, peptides become inductors of synthesis of the specific proteins, capable of restoring tissues, damaged by a disease or with ageing.
The efficiency of the conducted treatment course was evaluated according to the indices of visual acuity, electrophysiological test, eyeball image and subjective state of each patient. Improved visual functions were registered in 95% of the patients, which is absolutely unique. Nowadays in the world of medicine there are no methods of treatment for retinal diseases whose efficiency is comparable to that of the treatment with peptide bioregulators.
At our Medical Centre you can undergo the full course of the necessary ophthalmological examinations:
Consultation and complex examination
Eidoptometry with correction
Field of vision analysis
Fundoscopy with photorecording
Diagnostics of functional status of the lacrimal apparatus and lacrimal passages
Electrophysiological examination of retina
PRIORITY AREA OF CLINICAL ADMINISTRATION OF THE PEPTIDE BIOREGULATORS IN OPHTHALMOLOGY:
Macular degeneration: dry and wet forms
Recurrent post traumatic andpost-inflammatory retinal degenerations
Tapetoretinal eye degeneration
TREATMENT OF RETINAL PATHOLOGIES WITH PEPTIDE BIOREGULATORS
Retinitis pigmentosa - is one of the most severe and frequent hereditary retinal diseases. At the Medical Centre of the Institute we’d treated patients from different countries that failed to get any help in any other medical institutions and came to us after several years of desperate attempts to improve or stabilize their vision functions.
We should emphasize that right after the first treatment course they reported increased visual acuity, significant widening of the fields of vision, improved scotopic (twilight) vision. With every reason we may say that there are no examples of such positive results observed after the treatment of this pathology in the world. In case a patient regularly undergoes courses of peptide bioregulators we reveal no negative dynamics of this severe pathology at all.
Treatment of Retinitis Pigmentosa with peptide bioregulators
Age-related macular degeneration
Pathogenic pathway is influenced by oxidative stress, immune inflammations, lipidosis and hereditary background. It may also be related with smoking and elevated blood pressure.
In the developed countries of the world age-related macular degeneration is a leading cause of the blindness in patients aged 50+ . Thus the importance of regular preventive examination is extremely crucial. Such examinations enable to diagnose the degeneration on early stages and take necessary remedial measures accordingly.
Recently at the Saint Petersburg Institute of Bioregulation and Gerontology we have gained quite wide experience of treatment of such patients. We manage not only to stop the development of the pathologic process but in many cases also to restore lost functions. Peptide bioregulators are effective in the treatment of both wet and dry macular degenerations. The effect is preserved in case of long-term treatment. Regular application of peptide bioregulators allows to enhance the achieved results.
Treatment of Age-related macular degenerationwith peptide bioregulators